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Restless legs syndrome (RLS) is characterized by unpleasant sensations mainly in the legs.
43% of RLS-associated conditions have also been associated with systemic iron deﬁciency.
The objective of this study was to review in the literature the relationship between iron
metabolism and RLS. With an initial search using the keywords combination “Iron
Metabolism OR Iron Deﬁciency AND Restless Legs Syndrome,” 145 articles were screened,
and 20 articles were selected. Few studies were found for this review in the period of 2001–
2014, however, the correlation between RLS and iron was evident.
& 2014 Brazilian Association of Sleep. Production and Hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Restless legs syndrome (RLS) is characterized by uncomfortable
sensations in the lower limbs, although other body parts such as
the arms may be affected [1,2]. The symptoms are described as
sensations such as ‘creeping,’ ‘crawling,’ ‘tingling,’ ‘burning,’
‘cramping,’ ‘itching,’ ‘electric chocks,’ ‘stinging,’ ‘tension’ or ‘dis-
comfort’ in the lower limbs between the ankle and the knee [3].
There are two types of RLS: idiopathic and symptomatic
(secondary) [4]. The pathophysiology of idiopathic and sec-
ondary RLS is incompletely understood, local reduction of
dopamine content/expression in the central nervous system
seems to be a major cause of the symptoms [1,2].
Since the etiology of RLS is unknown, a central organizing
concept is needed to explain the vast number of conditionsep. Production and Hosti
licenses/by-nc-nd/3.0/).
o. 1300, CEP 13484-350 L
mp.br (A.M. Esteves).that trigger this well-deﬁned syndrome, reasonable thera-
peutic improvement by various pharmacological agents, the
evolving role of iron regulation and the various genetic loci
that have been associated with RLS in selected populations.
Reliable studies have demonstrated that 50% of restless legs
syndrome patients have a positive family history and it has
been suggested that RLS is a highly hereditary trait [4,5].
Restless legs syndrome is one of the few common neurolo-
gical disorders that exhibits signiﬁcant familial aggregation
[6]. Oexle et al. [7] found a correlation between RLS and iron
parameters in serum, but, it may be weaker than assumed.
In Weinstock and Walters [8], 43% of RLS-associated
conditions have also been associated with systemic iron
deﬁciency. Iron is distributed heterogeneously in different
regions and brain cells; brain iron homeostasis is required forng by Elsevier B.V. This is an open access article under the CC BY-
imeira, SP/Brazil. Tel./fax: þ55 19 3701 6706.
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common nutritional disorder worldwide, affecting more than 2
billion people ([10] apud [11]). Iron has a fundamental function
on the correct dopaminergic system operation, particularly
being a coenzyme of Tyrosine Hydroxylase; the evidences that
show us a possible dopaminergic dysfunction are several; most
of the genes involved have a relationship with dopamine
metabolism (gene of receptor D2, gene of receptor D4 DRD4,
gene of dopamine transporter DAT 1), and the recent articles of
functional neuroimaging bring a dopaminergic dysfunction at
the level of frontoestriatal circuit [12].
Thus, the objective of this study is to review in the
literature the relationship between the inﬂuences of iron
metabolism in RLS.2. Methods
A search on PubMed was established and the keywords used in
this search were ‘Iron Metabolism,’ ‘Iron Deﬁciency’ and ‘Rest-
less Legs Syndrome’; 145 articles were screened and we divided
them into different topics (Table 1). Discussions occurred to
select the articles within the stipulated period 2001 and 05/08/
2014 and the chosen keywords, and, 20 articles of the 145 found
were selected. The following data were extracted: (1) study
design, (2) patients characteristics, such as number of volun-
teers, age and gender and (3) consequences of iron deﬁciency in
RLS. Articles between 2001 and 05/08/2014 were used in the
study. As inclusion criteria, we used references that reﬂect our
personal selection of articles as being the most informative,
using only English articles.3. Results
3.1. Studies of the inﬂuences of iron metabolism in RLS
3.1.1. Relation with attention deﬁcit hyperactivity disorder
(ADHD)
Oner et al. [4] found RLS in 29 (33%) of the 87 ADHD children and
adolescent participants, they showed that depleted iron stores
might increase the risk of having RLS in ADHD subjects,
suggesting a correlation between RLS and ADHD. On the other
hand, Soto-Insuga et al. [12] did a study with 60 participants
(mean 9,02 years), and found patients with iron deﬁciency and
SPI, but did not reach any result of statistical signiﬁcance.Table 1 – Topics of the 145 articles screened.
Topics Number of articles
Restless legs syndrome 38
Atention deﬁcit hyperactivity disorder 5
Dopaminergic system disturbance 18
Pregnancy 5
Iron metabolism 33
Supplementation 9
Iron genes 10
Pharmacological treatment 23
Periodic limb movement 43.1.2. Dopaminergic system disturbance (DSD)
Several markers are important to know about dopaminergic
system, we included the dopamine, DAT (dopamine trans-
porter), dopamine receptors (DR1, DR2, DR3), Tyrosine hydro-
xylase (TH), found in putamen and substantia nigra.
Iron deﬁciency can be indicative of reduced activity of the
dopamine transporter (DAT) [11]. Earley et al. [13] found a
signiﬁcant decrease in DAT in two independent studies; these
results when viewed along with prior RLS, SPECT and autopsy
studies of DAT, and cell culture studies with iron deﬁciency
and DAT, suggest that membrane-bound striatal DAT, but not
total cellular DAT, may be decreased in RLS.
It is likely that majority of RLS patients have no degenera-
tion of dopaminergic neurons, which means that the machin-
ery to synthesize dopamine is not impaired [1].
In another point of view Connor et al. [14], in RLS tissue,
compared with controls, a signiﬁcant decrease in D2R in the
putamen that correlated with severity of the RLS; RLS also
showed signiﬁcant increases in TH in the substantia nigra,
compared with the controls, but not in the putamen. Both TH
and phosphorylated (active) TH were signiﬁcantly increased
in the substantia nigra and putamen; there were no signiﬁ-
cant differences in either the putamen or nigra for D1R. These
results support the idea that disturbance on dopaminergic
system can be the mean factor to symptoms of RLS. Results
conﬁrm the ability of iron deﬁciency and D3R/ to evoke
sensory and motor symptoms in mice resembling those
observed in the RLS patients [15].
3.1.3. Pregnancy
Prevalence and characteristics of RLS is more common in
women than in men [16]. RLS is much more common in
pregnant (approximately 26%) than in non-pregnant women
and frequently becomes worse or may appear for the ﬁrst time
during pregnancy [17]. Lower hemoglobin levels and supple-
mentation deﬁcits of iron and vitamins in pregnant women can
indicate a possible risk factor for RLS in pregnancy [18]. A few
weeks after therapy, both patients experienced a signiﬁcant
reduction or even remission of RLS symptoms; their quality of
life and sleep substantially improved and no treatment-related
adverse effects were observed [19].
3.1.4. Iron deﬁciency anemia (IDA)
Ferritin is increased in a number of conditions unrelated to iron
status. This may cause a false normal value in an individual with
truly low iron stores. Thus, a low value of ferritin is indicative of
true iron deﬁciency [20]. Allen et al. [21] evaluated 251 patients,
and they found for the ﬁrst time a reasonably accurate estimate
of RLS prevalence in a community population of patients with
IDA referred for treatment, thus conﬁrming the expectation of
high prevalence of clinically signiﬁcant RLS in IDA.
3.1.5. Supplementation
We can still have a discussion on literature about the oral
iron and intravenous iron sucrose. Mohri et al. [22] did a study
with 30 Japanese children with RLS, and the treatment with
oral iron supplementation was reported to be highly effective
in 17 children, effective in 10, and ineffective in 3 as Grote
et al. [2] found RLS scores consistently lower after using
intravenous iron sucrose, compared with placebo during all
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iron sucrose substitutes iron loss in blood donors more
efﬁciently compared with oral iron sulfate, especially
in women.3.1.6. Iron genes
Several lines of evidence suggest a hereditary link in patients
with idiopathic RLS; genetic linkage studies of large families
with many members affected by RLS have identiﬁed many
candidates' susceptibility [24]. Five gene variants have been
linked to RLS [25]. The functions of the ﬁve genes that were
identiﬁed (MEIS1, BTBD9, MAP2K5, LBXCOR1 and PTPRD) [26],
in addition, the gene BTBD9 in humans, have been associated
with restless legs syndrome and serum ferritin [27].4. Conclusion
The pathophysiology of RLS remains unclear, although roles
for dopamine dysfunction and brain iron deﬁciency have
been proposed [28]. A low ferritin level (o 50 ng/ml) is
documented in the literature to be related to RLS in the
general population [29]. Dysregulation of iron metabolic
pathways has been demonstrated in a large number of
neurodegenerative movement disorders [30]. Serum iron
levels have relationships with sleep quality, daytime sleepi-
ness, depression, fatigue, and quality of life [31].
Literature suggests future studies relating to levels of
iron and pregnancy, ADHD and RLS. Measurement of
hepcidin or pro-hepcidin in all RLS-associated disorders
and determination of whether reduction of inﬂammation
by treating the underlying systemic disorder could improve
RLS symptoms and alter CNS and/or peripheral hepcidin
and iron level also are important. And another point is
exploring immunological and inﬂammatory properties of
NOS, nitric oxide and the hypoxia inducible in the pathway
of RLS [5].
There are a lot of consensuses and evidences about RLS,
but the study and advances in research bring a line to
investigate the syndrome. Articles show the syndrome in
children, adolescents, adults and in pregnant women (in
different populations around the world), but the study's
line has been moving to iron deﬁciency. Few studies were
found (145) for this review in the period of 2001–2014,
however, the correlation between RLS and iron was evi-
dent as shown in the articles about ADHD, dopamine
system disturbance, pregnancy, IDA, supplementation
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